US 10881738
Oligomer-beta blocker conjugates
granted A61KA61K47/60A61P
Quick answer
US patent 10881738 (Oligomer-beta blocker conjugates) held by Nektar Therapeutics expires Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Nektar Therapeutics
- Grant date
- Tue Jan 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 31 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K47/60, A61P, A61P25/06, A61P25/22